|Place of Origin:||China|
|Minimum Order Quantity:||3000 PCS|
|Packaging Details:||Standard Packing Carton|
|Supply Ability:||500000 PCS per Month|
|Product Name:||Chlamydia Pneumoniae CPN Antibody IgG Rapid Test Kit||Properties:||Pathological Analysis Equipments|
|Sample:||Availalble||Type:||Pathological Analysis Equipments|
Chlamydia Pneumoniae Pathological Analysis Equipments CPN Antibody IgG Rapid Test Kit
|Product: Chlamydia Pneumoniae CPN Antibody IgG Rapid Test Kit||Logo:Customer's Logo|
|Instrument classification:Class II||Storage:4-30'C|
|Specimen:Serum/Plasma/Whole Blood||Certificate:CE/ ISO13485|
|Dimension:4.0mm||Shipping:By sea/By air/TNT/Fedex/DHL|
The reagent is used to detect the Chlamydia Pneumoniae IgG antibody in serum / plasma qualitatively. Chlamydia pneumoniae
is the causative agent of respiratory tract nfectious diseases and spread worldwidely through aerosols. Chlamydia pneumonia
may cause pneumonia, bronchitis, pharyngitis, sinusitis, stimulate primary pharyngitis. 10~20% of adults and children may
get community acquired pneumonia according to chlamydia pneumonia, while 10~20% adults may get acute bronchitis. In fact,
most of the chlamydia pneumoniae infection is in the type of subclinical, with no symptoms and rarely cause significant
disease, and will be much more serious without treatment. The positive results of infected people showed that the
concentration of chlamydia pneumoniae goes with age, which is lower in children but peaking in middle-aged people. It is
indicated that chronic infection of Chlamydia pneumoniae is one of the factors that cause the atherosclerosis. The
diagnosis of Chlamydia pneumoniae infection by serological methods is still one of the bases for clinical diagnosis so far.
Detection of chlamydia pneumoniae antibody is widely used in clinical diagnosis for its simple operation, quickness and low
cost. In normal infection, Cpn-IgM can be detected as early as 3 weeks after infected, while Cpn-IgG can be detected in
about 3-5 weeks.
The test utilizes antibodies including a recombinant antigen Cpn and mouse anti-human monoclonal antibody on the
nitrocellulose membrane with colloidal gold marked Cpn antigen as an mark tracer. The reagent is used to detect the Cpn IgG
antibody in serum / plasma according to the principle of double antibody sandwich method and gold immunochromatography
assay. The sample mixing up mouse anti-human antibody–marker move along the membrane to the T line, and form the T line
when the sample contains Cpn-IgG antibody, which a positive result. Conversely, it is a negative result.
Newlystar (Ningbo) Medtech Co.,Ltd. is one of the leading supplier for Pathological Analysis Equipments,
Diabetes Treatment Equipment and Finished Pharmaceutical from China. With a proven track record of
passed years,Newlystar-Medtech has been recognized by her customers as a high-quality and reliable
supplier notonly on products, but also on assistance for audit and improvement of GMP level, quality
management system, EHS management system and registration dossier support, etc.The essence of
Newlystar-Medtech's activites, is a commitment to her customers with professional service and high-quality
products with effective cost and innovative solutions.
All medical product work in Newlystar-Medtech like a bridge link the customers and Chinese manufacturers,
especially, their professional working is to make the formulation manufacturers who is familiar with
Chinese medical product to understand well the international requirement,to ensure the success of customers.
The advantages on professional working and strongly representative base on first-class manufacturing partners
in China, enable Newlystar-Medtech to provide her customers with a wide range and high-tech products,
best services and capabilities for their actions in tender, distributing and improvement in their national healthcare
system. Newlystar-Medtech also dedicates herself to sourcing quality medical products for Chinese market.